Full opinion text
MEMORANDUM AND ORDER McLAUGHLIN, District Judge. In this consolidated class action, the plaintiffs allege that the defendants, Radian Group, Inc. (“Radian”), Sanford A. Ibrahim, C. Robert Quint, and Mark A. Casale, committed securities fraud in violation of sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (“Exchange Act”), and Securities and Exchange Commission (“SEC”) Rule 10b-5, 17 C.F.R. § 240.10b-5. The action is brought on behalf of purchasers of Radian securities between January 23, 2007, and August 7, 2007. Radian provides credit protection products and financial services to financial institutions, including mortgage lenders. Credit-Based Asset Servicing and Securitization (“C-BASS”), a corporation in which Radian held a 46% equity interest during the class period, invested in the credit risk of subprime residential mortgages. The plaintiffs allege that the defendants made false and misleading statements about C-BASS’s profitability and liquidity position and thus, the value of Radian’s investment in C-BASS, during the class period. These statements are alleged to have artificially inflated Radian’s stock price, which led to losses to shareholders when Radian announced an impairment of its investment on July 30, 2007. The defendants have moved to dismiss the consolidated class action complaint (“CCAC”). Their main arguments for dismissal of the plaintiffs’ § 10(b) claim are: (1) that the plaintiffs’ allegations of fraud do not satisfy the heightened pleading requirements of the Private Securities Litigation Reform Act (“PSLRA”), 15 U.S.C. § 78u-4, particularly with respect to the required showing of a “strong inference of scienter”; and (2) that the defendants’ statements constitute forward-looking statements that are nonactionable under the PSLRA’s safe harbor provision, 15 U.S.C. § 78u-5(e). They further argue that because the plaintiffs have not stated an independent securities violation under § 10(b), they have also failed to state a § 20(a) claim. Because the Court finds that the plaintiffs have not carried their burden of showing a strong inference of scienter, the Court will grant the defendants’ motion. I. Facts as Alleged in the Complaint Radian is a credit enhancement company that offers mortgage insurance and other financial services and products to mortgage lenders and other financial institutions. Sanford A. Ibrahim, at all relevant times, was Radian’s CEO, and a member of Radian’s Board of Directors. C. Robert Quint was Radian’s CFO and Executive Vice President. Mark A. Cásale served as President of Radian Guaranty, Inc., a Radian subsidiary, and was also a member of C-BASS’s Board of Managers during the class period. CCAC ¶¶ 2, 12, 13. During the class period, Radian’s operations were divided into three business segments: (1) mortgage insurance; (2) financial guaranty; and (3) financial services. In 2006, the mortgage insurance segment represented 49% of Radian’s net income, and 55% of its equity; the financial guaranty segment represented 23% of Radian’s net income, and 34% of its equity; and the financial services segment represented 28% of Radian’s net income, and 11% of its equity. Id. ¶ 44. During the class period, Radian’s financial services segment consisted mainly of interests held in Sherman Financial Services Group, LLC (“Sherman”), and C-BASS. Sherman purchases and services charged-off and bankruptcy plan consumer assets at discounts from national financial institutions and major retail corporations. Sherman also originates nonprime credit card receivables through a subsidiary. Id. ¶ 48. C-BASS, on the other hand, is a mortgage investment and servicing company that specializes in subprime residential mortgage assets and mortgage-backed securities (“MBS”). During the class period, Radian held a 46% equity interest in C-BASS, and had invested approximately $500 million in it. C-BASS was a joint venture between Radian and MGIC Investment Corporation (“MGIC”), another provider of private mortgage insurance that also held a 46% interest in C-BASS. During the class period, C-BASS serviced loans through a wholly owned subsidiary, Litton Loan Servicing, LP (“Litton”). Id. ¶¶ 4, 49, 51. A. Radian, C-BASS, and the Sub-prime Market The CCAC alleges that prior to and during the class period, the MBS securitized by C-BASS became particularly risky because they were backed by sub-prime loans, which themselves had become risky. In addition, the largest proportion of mortgages that had been purchased by C-BASS were located in California and Florida, two locations which the New York Times had reported as accounting for about 21% of all mortgages nationally, and 30% of new foreclosures. Further compounding the riskiness and volatility of C-BASS’s assets was the fact that C-BASS did not originate the loans it serviced and securitized, which, according to the plaintiffs, increased the risk that these loans were fraudulently originated. C-BASS also retained the most risky interests in the securitizations it created, including, for example, by accepting the first risk of payment default. Id. ¶¶ 52, 56, 57, 61, 63. Prior to the class period, interest rates began to rise nationally, which adversely affected subprime borrowers’ ability to pay and increased the default risk of subprime mortgage loans. According to the plaintiffs, the deterioration of the subprime market gave rise to a material increase in mortgage loan defaults, thus significantly impairing the value of C-BASS’s subordinated securitized interests. Because C-BASS had been heavily dependent on bank credit lines for its liquidity, the impaired value of C-BASS’s subordinated securitized interests, which had served as the collateral for its bank loans, caused “a monumental liquidity crisis” for C-BASS. Id. ¶¶ 65-67. The CCAC lists additional factors that it claims contributed to “an increasingly difficult operating environment at C-BASS.” First, it states that C-BASS began to experience an increase in early payment defaults by borrowers, indicating that the borrowers of the loans purchased by C-BASS had not been properly qualified. Second, there was an increase in investor rejections of loans that C-BASS sought to securitize, which was primarily the result of defective appraisals, incorrect credit reports, and missing documentation. This forced C-BASS to find other investors, who often offered less attractive terms for the loans, or to place the loans in its own portfolio. C-BASS further experienced an increase in mortgage delinquency rates, but also purchased “increasingly risky mortgage products.” Finally, the sub-prime market had become increasingly competitive, as evidenced by shrinking margins between the interest rates on purchased loans and the rates offered to the purchasers of C-BASS’s securitizations. Id. ¶ 78. According to the CCAC, a number of former employees of C-BASS and Radian Guaranty, a Radian subsidiary, stated that the deteriorating conditions experienced generally by subprime market participants prior to and during the class period caused the quality of the subprime mortgage pools securitized by C-BASS to decline. CW 3, a former C-BASS employee, said that default rates increased during 2006 into 2007. CW 2, another former C-BASS employee, stated that there was a continuous decline in the quality of loans C-BASS purchased beginning in 2005, and that from 2005 to 2007, C-BASS purchased increasing amounts of high-risk loans. Id. ¶¶ 79-81. The CCAC further claims that C-BASS’s management knew how poor its mortgage pools were performing during the class period because Litton’s website states that “Litton services every C-BASS issued deal.” Nonetheless, C-BASS was intent on securitizing defective mortgages so that it could procure the liquidity necessary to purchase more subprime loans. CW 1 also stated that C-BASS was so eager to purchase mortgages that, in many instances, C-BASS would “eat” bad loans it purchased even though it had the right to “put” loans back to the originators. Id. ¶¶ 82, 87. CW 1, a former C-BASS employee, “indicated” that Radian was “knowledgeable” about loans in C-BASS’s portfolio because it maintained a systematic process for monitoring instances when borrowers defaulted on mortgage loans. CW 4, a former Vice President of Radian Guaranty, stated that beginning in 2006, he and other senior members of Radian’s management readily witnessed a higher rate of loan delinquencies. CW 5, another former Vice President of Radian Guaranty, acknowledged an increase in riskier residential mortgage loans in the market in 2006 and stated that Radian was hesitant to insure such loans. CW 5 further recalled that defaults and foreclosures began to rise in the 2005-2006 time frame, which resulted in an increase in claims filed against Radian. Id. ¶¶ 84-86. The plaintiffs claim that the combination of adverse subprime conditions and high-risk operations resulted in margin calls to C-BASS from its creditors. These calls significantly drained C-BASS of liquidity, leaving C-BASS without sufficient cash to operate and impairing the value of Radian’s investment in C-BASS. The CCAC further alleges that the defendants knew or recklessly ignored the situation at C-BASS based on the fact that Radian and C-BASS maintained a close business relationship. Id. ¶¶ 93-94. Various statements made by the defendants are alleged in support of the CCAC’s contention that Radian and C-BASS maintained a close business relationship. These statements include: (1) a statement in a letter from Ibrahim to Radian’s shareholders in the Company’s 2005 Annual Report, which stated that “[i]n holding board seats ... Radian maintains an active involvement in strategic activities at both C-BASS and Sherman Financial”; (2) another statement in the 2005 letter that “Mark [Casale], who sits on the boards of C-BASS and Sherman Financial ..., has the additional responsibility of driving growth for the mortgage credit risk business”; (3) a statement by Ibrahim in a letter in the Company’s 2006 Annual Report that Radian’s “relationships with C-BASS and Sherman ... provide timely and valuable insights into the consumer-credit marketplace.” The defendants also point to a statement on Litton’s website that Litton aims to “ensur[e] the interests of C-BASS, Litton, Litton’s customers, and ... investors are aligned. This integration of what were traditionally separate mortgage business lines is what makes [Litton] unique ....” Id. ¶¶ 94-97. B. Allegedly Misleading Statements Made During the Class Period The class period begins on January 23, 2007. On that date, Radian issued a press release announcing its financial results for the fourth quarter and fiscal year of 2006. For fiscal year 2006, the company reported a net income of $582.2 million and diluted net income of $7.08 per share. Ibrahim commented: Radian delivered record net income and grew book value by 16.1 percent, despite a challenging operating environment ... This performance demonstrates that our strategy to focus on diversification while maintaining a strict risk management culture continues to deliver long-term value. Forecasts for interest rate stability, strong employment and improved persistency bode well for the mortgage insurance industry. In this environment, we believe we are well positioned to benefit over the long term from both cyclical and structural opportunities in the mortgage market. Id. ¶ 131. With respect to C-BASS, Ibrahim further stated that “[i]n the Financial Services segment, both C-BASS and Sherman continued to be important and steady contributors to Radian’s results.” Id. The next day, January 24, 2009, Radian held a conference call with analysts and investors to discuss Radian’s earnings and operations. During the call, Quint stated: During the fourth quarter, C-BASS recovered most of the hedge losses that had been booked in prior quarters. While the subprime origination business is in a state of uncertainty, an environment like this typically creates opportunities for C-BASS to purchase mispriced assets. We feel good about C-BASS’s prospects for 2007, although there is clearly some uncertainty around these expectations. Id. ¶ 132. Following the statements on January 23 and 24, the price of Radian stock rose to $60.18 per share. Id. ¶ 133. On February 6, 2007, Radian and MGIC announced that they had agreed to merge. They also announced that they had agreed to sell half of their combined interest in C-BASS. According to CW 1 — a C-BASS employee — the sale of C-BASS would add greatly to the value of MGIC and Radian shares because C-BASS’s financial statements would not have to be consolidated with the combined entity, thereby excluding its debt from the combined entity’s balance sheet. Id. ¶ 121. On March 1, 2007, Radian filed its form 10-K for the fiscal year ending December 31, 2006. This form reported that Radian’s net income attributable to its financial services segment was $257.0 million for 2006, of which C-BASS accounted for $133.9 million. The form further reported that: As a holder of credit risk, our results are subject to macroeconomic conditions and specific events that impact the credit performance of the underlying insured assets. We experienced generally positive results throughout the business for the year ended December 31, 2006, led by strong credit performance and good production despite the challenging business production environment for mortgage insurance and financial guaranty insurance. For 2006, the financial services segment showed another year of strong earnings and return on investment, which was, in part, a result of the relatively low interest rate and favorable credit environment ... In addition, both C-BASS and Sherman were positively impacted in the fourth quarter of 2006 ... and C-BASS recovered most of the hedge losses that had been incurred in prior quarters. Despite the significant credit spread widening that has occurred in the subprime mortgage market during the first quarter of 2007, which could produce ... losses for C-BASS during the first quarter, we expect that both C-BASS’s and Sherman’s results for 2007 will remain fairly consistent with their 2006 results, as both companies stand to benefit from recurring sources of earnings ... and, while the sub-prime origination business is currently uncertain, C-BASS typically looks for opportunities to purchase mispriced assets in such an environment. Id. ¶ 134. Included in this filing was a certification that Radian’s CEO and CFO had “evaluated the effectiveness” of the company’s “disclosure controls,” and that “there was no change in [Radian’s] internal controls over financial reporting that occurred during the fourth quarter of 2006 that has materially affected, or is reasonably likely to materially affect, [Radian’s] internal control over financial reporting.” Id. ¶¶ 126-27. On April 24, 2007, Radian issued a press release announcing its financial results for the first quarter of 2007, ending March 31, 2007. The company reported net income of $113.5 million and diluted net income per share of $1.42. Ibrahim commented: Our primary book was not significantly affected by the disruptions in the subprime market in recent months. I believe this is a validation of our long-term approach to risk management in all areas, including sub-prime and Alt A, where we have remained disciplined in diversifying our book of business across geographies, products, clients and origination years. Id. ¶ 136. With regard to C-BASS, the company stated that “In the financial services segment, net income was $10.8 million, down from ... the same period last year, primarily as a result of an operating loss at C-BASS.” Id. The next day, April 25, 2007, Radian held a conference call with analysts and investors. During the call, Ibrahim stated: C-BASS reported a disappointing first quarter. As most of you learned from Bruce Williams, co-founder and CEO of C-BASS, who joined the MGIC earnings call earlier this month, C-BASS reported a pre-tax loss for the first quarter. As Bruce mentioned, the company expects a return to profitability in the second quarter and a pre-tax return for the year of 15% to 20%, which translates into $150 to $200 million in pre-tax earnings for the full year, of which Radian’s share is 46%. The full transcript of Bruce’s remarks is available on our website in the SEC filings. Id. ¶ 138. During the call, Quint also remarked: You have obviously heard a lot about C-BASS’s first quarter, along with the expectation for improvement over the rest of the year as they expect the market to stabilize at current levels. We have started to see some evidence of this stabilization in the second quarter. Id. In addition, the following exchange took place between the individual defendants and Bruce Harting, an analyst from Lehman Brothers: HARTING: On the C-BASS, understanding that Bruce Williams said that, but is it just simply that the inventory of loans had to be repriced; and now we move forward at a tighter bid? I didn’t quite follow the logic on why the immediate return to profitability. QUINT: The portfolio is marked-to-market based on the changed spread. So at this point, they are comfortable that they can resume profitability. HARTING: Have they seen real-time signs of bids for their securitizations? CASALE: Oh, yes. Remember, Bruce, they executed securitizations through that, even through the turmoil, which is a testament to their name and reputation in the market. It is just when, at the end of the quarter, when they had to mark this stuff it was at an all-time wide. Spreads were at an all-time wide. IBRAHIM: Again, Bruce, as you know, when these kind of market conditions occur, while everybody gets hurt, the most respected players in the market enjoy better executions than the others. The differentiation widens. So being the best player in a tough group of peers means you get hurt, but you also get hurt less. Id. ¶ 140. On May 10, 2007, Radian filed its Form 10-Q for the first quarter of 2007, the period ending March 31, 2007. This form reported that Radian’s net income attributable to the financial services segment for the first quarter of 2007 was $10.0 million and that “equity in net income of affiliates” decreased 61% to $22.8 million for the quarter, which was driven by a $6.8 million loss related to C-BASS. The form stated: As a holder of credit risk, our results are subject to macroeconomic conditions and specific events that impact the production environment and credit performance of our underlying insured assets. We experienced mixed results during the first quarter of 2007. Positively, we had strong production in both mortgage insurance and financial guaranty insurance. However, mortgage insurance losses incurred were higher than expected and our financial services segment results were negatively impacted by the subprime mortgage market disruption which significantly affected C-BASS’ financial performance in the quarter. For the quarter ended March 31, 2007, the financial services segment had mixed results. Sherman continued its consistent strong earnings; however, C-BASS incurred a loss of approximately $15 million as credit losses and credit spread widening in the subprime mortgage market impacted their results.... C-BASS is expected to return to profitability over the balance of the year, assuming the subprime mortgage stabilizes at current levels. Id. ¶ 142. The report also deemed the fair value of C-BASS to be greater than $967 million. The CCAC alleges, however, that the decline in the value of C-BASS’s securitizations and other assets, which had collateralized C-BASS’s loans, resulted in massive margin calls from lenders that left C-BASS on the “verge of bankruptcy” by March 31, 2007. The fair value of Radian’s investment in C-BASS at that point, according to the CCAC, was “materially less” than the $445 million carrying value reported by the May 10, 2007, Form 10-Q. This filing also stated: ‘We have presented our condensed consolidated financial statements on the basis of accounting principles generally accepted in the United States of America.” Id. ¶¶ 109, 113, 117, 118. On July 24, 2007, Radian issued a press release announcing its financial results for the second quarter of 2007. The company reported net income of $21.1 million and diluted net income per share of $0.26. Ibrahim commented: Our second quarter results clearly illustrate the credit challenges in today’s mortgage market, but I believe they also reflect long-term positive trends for our business. Market conditions, particularly in California and Florida, led to an increase in defaults that impacts our results. Id. ¶ 144. The next day, July 25, 2007, Radian held a conference call with investors. During this call, when questioned by an analyst about C-BASS’s liquidity situation, Quint replied: [B]ecause they are in a — the sale process that we’re in right now it’s not really appropriate to discuss the specific liquidity situation. But I think we should reiterate that the whole market is going through a tough challenge with regard to liquidity and that includes C-BASS. Id. ¶ 145. Another analyst asked whether C-BASS was liquidating some of its assets at depressed values, in particular, certain bonds. Quint and Casale replied as follows: QUINT: I don’t know where you got that information. I’m nob — I don’t think that was ever spoken about. CASALE: And they are not selling any bonds .... The questioner further asked whether, “to the extent [C-BASS was] forced to ... cover margin cost ... are they in that position right now where they are forced to liquidate some of these positions?” Cásale replied, “No, they are not.” Id. ¶ 145. C. Announcement of Impairment and Subsequent Events On July 30, 2007, Radian issued a press release announcing that the value of its investment in C-BASS had been “materially impaired.” The press release announced that “[s]ince February 2007, the market for subprime mortgages has experienced turmoil.” The company further disclosed that its investment in C-BASS consisted of approximately $468 million of equity as of June 30, 2007, and an additional $50 million drawn on July 20 and 23, 2007, under a $50 million unsecured credit facility that Radian provided to C-BASS. The company also represented that although it had not determined the level of the impairment charge, it “could be Radian’s entire investment, less any associated tax benefit.” Ibrahim commented: While this action clearly reflects the continuing credit challenges in today’s mortgage market, we are moving forward, as planned, with our proposed merger with MGIC, which we expect to close late in the current quarter, or early in the next. Id. ¶ 147. After this announcement, the price of Radian stock declined from $40.20 per share to $33.71 per share. Id. ¶ 148. On July 31, 2007, C-BASS issued a press release, which stated: While nothing fundamentally has changed at C-BASS, like many other firms in the industry, the current severe state of disruption in the credit markets has caused C-BASS to be subject to an unprecedented amount of margin calls from our lenders. The frequency and magnitude of these calls have adversely affected our liquidity. To address this, C-BASS is in advanced discussions with a number of investors to provide increased liquidity and is exploring all options to mitigate the liquidity risk in this difficult market. At the beginning of 2007, we had $302 million of liquidity, representing greater than 30% of our capital of $926 million. During the first 6 months of 2007, a very tumultuous time in the subprime mortgage market, C-BASS’ disciplined liquidity strategy enabled the company to meet $290 million in lender margin calls. During the first 24 days of July alone, C-BASS met an additional $260 million of margin calls, representing greater than a 20% decline in the lender’s value. We believe that nothing justifies this substantial amount of margin calls received in such a short period of time, particularly as there has been no change in the underlying fundamentals of our portfolio. Id. ¶ 149. After this announcement, the price of Radian stock fell from $33.71 to $27.51 per share. Id. ¶ 150. On August 7, 2007, MGIC issued a press release stating that, in light of the C-BASS impairment, MGIC was not required to complete its pending merger with Radian. According to the press release, Radian told MGIC that it disagreed with MGIC’s assessment of the merger obligations. After this announcement, the price of Radian common stock declined from $23.23 to $20.62 per share. Id. ¶¶ 151-52. On September 5, 2007, Radian and MGIC jointly announced that they had agreed to terminate the pending merger. According to the press release they issued, the “current market conditions have made combining the companies significantly more challenging. Both MGIC and Radian believe it is in their best interests to remain independent companies at this time.” Id. ¶ 153. On October 2, 2007, Radian filed a Form 8-K with the SEC, announcing that Deloitte & Touche LLP (“Deloitte”), who had previously served as Radian’s independent auditor, declined to stand for reappointment for 2007. According to the Form: Deloitte ... is the independent registered public accountant for Radian Group Inc. (the “Company”). Deloitte’s present engagement with the Company had been expected to terminate on or about the filing of the Company’s Quarterly Report on Form 10-Q for the third quarter of 2007 (the “Termination Date”) had the Company completed its merger with [MGIC]. As previously disclosed, Radian and MGIC mutually terminated their proposed merger on September 5, 2007. On September 26, 2007, Deloitte declined to stand for reappointment as the Company’s independent auditors for the 2007 audit and its engagement will end shortly following the Termination Date. During the Company’s two most recent fiscal years and the subsequent interim periods preceding September 26, 2007: (i) there were no “reportable events” ... and (ii) there was no “disagreement” ... between the Company and Deloitte on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement, if not resolved to the satisfaction of Deloitte, would have caused Deloitte to make reference to the subject matter of the disagreement in connection with its report, except as follows: As previously reported on a Form 10-Q/A dated August 13, 2007 (the “10-Q/A”), on August 9, 2007, the Company filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2007 (the “Second Quarter 10-Q”), before Deloitte had completed its review of the interim financial statements included in the Second Quarter 10-Q. As reported in the 10-Q/A, Deloitte needed to review additional documentation supporting the conclusion that the impairment charge relating to the Company’s interest in [C-BASS] occurred after June 30, 2007. Members of the Company’s management discussed the events surrounding the filing of the Second Quarter 10-Q with Deloitte on August 9, 2007, and the Chairman of the Company’s Audit and Risk Committee discussed these events with Deloitte on August 10, 2007. On August 14, 2007, the Company filed a second amendment to its Second Quarter 10-Q to state that the matters related to the impairment had been resolved without changes or amendments to the interim financial statements included in the Second Quarter 10-Q. The Company has authorized Deloitte to respond fully to the inquiries of any successor accountant concerning this matter or any other matter. Id. ¶ 154. According to the CCAC, throughout the class period, the “defendants” sold 161,804 shares of their Radian stock, generating proceeds of approximately $10.2 million. Ibrahim is alleged to have sold 1,095 shares on February 14, 2007, and 5,040 shares on May 14, 2007, representing a total of $384,000 in stock sales. Quint is alleged to have sold 129,000 shares of Radian stock on February 8, 2007, representing a sale of approximately $8,105,070. Id. ¶ 162. II. Discussion The CCAC presents two claims against the defendants: (1) securities fraud under § 10(b) of the Exchange Act; and (2) control person liability under § 20(a) of the Exchange Act. The plaintiffs argue that during the class period, the defendants materially misled the investing public by issuing false and misleading statements that failed to notify shareholders of the margin calls that C-BASS had received, to state a proper value of Radian’s investment in C-BASS, or to write down that investment in a timely fashion. Rather than disclose this impairment, the defendants downplayed C-BASS’s liquidity crisis, and deceptively stated that C-BASS was expected to return to profitability. As a result of these statements, the plaintiffs claim, Radian’s common stock traded at artificially inflated prices during the class period, which ultimately led to losses when Radian finally announced an impairment of its investment in July 2007. The defendants have moved to dismiss the CCAC, arguing: (1) that the plaintiffs fail to allege facts giving rise to a strong inference of “scienter,” a necessary element of a § 10(b) violation; (2) that the plaintiffs do not allege with sufficient particularity that the statements at issue were false when made; and (3) that, in any event, the statements were forward-looking statements and are thus nonactionable under the PSLRA’s safe-harbor provision, 15 U.S.C. § 78u-5(c). As for the plaintiffs’ § 20(a) claim, the defendants argue that there can be no violation of § 20(a) without an independent federal securities violation. The Court finds that the allegations of the CCAC do not raise a strong inference that any of the defendants acted with scienter, as required by the PSLRA. The Court will therefore dismiss the plaintiffs’ § 10(b) claim. The Court will also dismiss the plaintiffs’ § 20(a) claim for failure to allege an independent violation of the securities laws. A. Section 10(b) Claim Section 10(b) of the Exchange Act forbids the use or employment of any deceptive device in connection with the purchase or sale of any security. 15 U.S.C. § 78j(b). Rule 10b-5 forbids the making of any “untrue statement of a material fact” or the omission of any material fact needed to make the statements not misleading. 17 C.F.R. § 240.10b-5. Courts have implied a private damages action from the statute and the rule, and Congress has imposed statutory requirements on that private action. The basic elements of the action are: (1) a material misrepresentation or omission; (2) scienter; (3) a connection with the purchase or sale of a security; (4) reliance on the misrepresentation; (5) economic loss; and (6) loss causation — a causal connection between the material misrepresentation and the loss. Dura Pharm., Inc. v. Broudo, 544 U.S. 336, 341-42, 125 S.Ct. 1627, 161 L.Ed.2d 577 (2005). Rule 10b-5 claims are governed by the PSLRA. The PSLRA heightened the pleading requirements in private securities actions. In re Rockefeller Ctr. Props., Inc. Sec. Litig., 311 F.3d 198, 217 (3d Cir.2002). It requires securities plaintiffs to specify with particularity at the outset of litigation all facts upon which they base their allegations or upon which they form their belief (if an allegation is made on information and belief). They must also specify each statement alleged to have been misleading and the reason or reasons why the statement is misleading. 15 U.S.C. § 78u-4(b)(1)(B); Winer Family Trust v. Queen, 503 F.3d 319, 326 (3d Cir.2007). Where there are multiple defendants, the plaintiffs must specify the role of each defendant, demonstrating each defendant’s connection to the misstatements or omissions. Winer, 503 F.3d at 336. On a motion to dismiss, a § 10(b) claim must satisfy the heightened pleading requirements of both the PSLRA and Rule 9(b) of the Federal Rules of Civil Procedure. Rule 9(b) requires, at a minimum, that the plaintiffs support their allegations of securities fraud with all of the essential factual background that would accompany “the first paragraph of any newspaper story” — that is, the “who, what, when, where and how” of the events at issue. In re Rockefeller, 311 F.3d at 217. Rule 9(b) also requires plaintiffs to show that the person responsible for the alleged misstatement or omission had knowledge that the misstatement or omission was false or misleading. Id. at 216. The PSLRA also heightened the standard for pleading scienter. 15 U.S.C. § 78u-4(b)(2). With respect to each act or omission, a plaintiff must: (1) specify each statement alleged to have been misleading and the reasons why it is misleading; and (2) state with particularity facts giving rise to a strong inference that the defendant acted with the required state of mind. Tellabs v. Makor Issues & Rights, Ltd., 551 U.S. 308, 127 S.Ct. 2499, 2507-08, 168 L.Ed.2d 179 (2007). Under Tellabs, the strong inference standard requires an inference of scienter to be more than merely reasonable or permissible. The Court held that a complaint will survive only if a reasonable person would deem the inference of scienter cogent and at least as compelling as any plausible opposing inference that could be drawn from the facts alleged. Id. at 2509. The Tellabs Court outlined a three-step process for considering motions to dismiss under § 10(b): First, a district court must accept all factual allegations as true, as with any motion to dismiss. Next, the court must consider the complaint in its entirety, including documents incorporated into the complaint by reference and matters of which the court may take judicial notice, and examine whether all of the facts alleged, taken collectively, give rise to a strong inference of scienter. Finally, the court must consider plausible opposing inferences to determine whether the pleaded facts meet the PSLRA’s strong inference standard. Id. Prior to Tellabs, a line of cases decided by the United States Court of Appeals for the Third Circuit held that a strong inference of scienter can be established by alleging either (1) facts to show that the defendants had the motive and opportunity to commit fraud; or (2) facts that constitute strong circumstantial evidence of conscious misbehavior or recklessness. In re Suprema Specialties, Inc. Sec. Litig., 438 F.3d 256, 276 (3d Cir.2006); In re Alpharma Inc. Sec. Litig., 372 F.3d 137, 148 (3d Cir.2004); GSC Partners CDO Fund v. Washington, 368 F.3d 228, 237 (3d Cir.2004). In Tellabs, the Supreme Court specifically reserved the question of whether recklessness could give rise to civil liability under 10b-5. It noted, however, that every court of appeals to consider the issue has held that a plaintiff can meet the scienter requirement by showing that a defendant acted intentionally or recklessly. Nonetheless, the question of whether a showing of recklessness satisfies the scienter requirement was not presented in Tellabs. 127 S.Ct. at 2507 n. 3. The relationship between Tellabs and the standard for establishing a strong inference of scienter in the Third Circuit is clarified by the Winer decision. In that case, the court of appeals affirmed the district court’s finding that the pleaded facts did not support a strong inference of reckless or intentional conduct. Id. at 331. “Stated differently, Winer’s purported inference, that the statements ... were knowingly false, was not as compelling or as strong as the opposing inference cited by the District Court. Thus, Winer’s inference is neither cogent, nor compelling, nor strong in light of competing inferences.” Id. Under Winer, then, a plaintiffs inference that a defendant’s alleged actions are reckless or intentional must be compared to any nonculpable inference offered by the defendant, and must be cogent and at least as compelling as any such nonculpable inference in order for the complaint to give rise to a strong inference of scienter. In examining the allegations of the complaint in this case, the Court must first accept all the allegations of the complaint as true. Next, considering the complaint in its entirety, as well as documents of which the Court may take judicial notice, the Court must decide whether all of the facts alleged, taken collectively, give rise to a strong inference of scienter — i.e., whether they establish either (1) motive and opportunity or (2) conscious misbehavior or recklessness. Finally, with respect to each of those standards for establishing a strong inference of scienter, the Court must also consider plausible opposing inferences to determine whether the pleaded facts meet the PSLRA’s strong inference standard. The Court concludes that the plaintiffs’ allegations, taken collectively and in conjunction with matters of which the Court may take judicial notice, do not establish either motive and opportunity or conscious misbehavior or recklessness on the part of the defendants. The plaintiffs therefore have not raised a strong inference of scienter. Even if these allegations were sufficient to establish either motive and opportunity or conscious misbehavior or recklessness, however, the Court also concludes that an inference of scienter with respect to the plaintiffs’ allegations is neither cogent nor at least as compelling as the plausible opposing inferences suggested by the defendants. 1. Motive and Opportunity Plaintiffs alleging motive and opportunity must support their assertions with facts stated with particularity. Bare allegations that the defendants “knew” or “must have known” that statements were fraudulent are insufficient. GSC Partners, 368 F.3d at 239. Blanket assertions of motive and opportunity also do not suffice; nor do “catch-all allegations that defendants stood to benefit from wrongdoing and had the opportunity to implement a fraudulent scheme.” Id. at 237. Motives that are generally possessed by most corporate directors and officers are also inadequate to satisfy the scienter requirement; instead, plaintiffs must assert a concrete and personal benefit to the individual defendants resulting from the fraud. Id. In every corporate transaction, the corporation and its officers have a desire to complete the transaction, and officers usually will reap financial benefits from a successful transaction. If allegations that a corporate defendant desired to retain his position or realize gains on company stock were sufficient to raise a strong inference of scienter, the directors of virtually every company would be forced to defend securities transactions every time a company effected a merger or acquisition. GSC Partners, 368 F.3d at 237-38 (citing Phillips v. LCI Int’l, Inc., 190 F.3d 609, 623 (4th Cir.1999)); see also Chill v. Gen. Elec. Co., 101 F.3d 263, 268 n. 5 (2d Cir.1996) (“If we accept ... as motive that every publicly-held corporation desires its stock to be priced highly by the market ... the motive requirement becomes meaningless.”). In support of them claim that the defendants had the motive to commit fraud, the plaintiffs assert that the defendants misrepresented and concealed information related to C-BASS in order to (1) consummate the merger with MGIC and (2) to allow the defendants and “other insiders” to sell off approximately $10.2 million of their personal holdings in Radian. Pis.’ Opp. 32. These alleged motives do not establish a strong inference of scienter. In addition, the Court finds that the plausible opposing inferences offered by the defendants with respect to the defendants’ alleged insider trading are more compelling than an inference of scienter. a. The MGIC Merger The plaintiffs allege that the defendants delayed recognizing the C-BASS impairment because doing so might have jeopardized the pending merger between Radian and MGIC, as Radian was required to sell its interest in C-BASS to complete the merger. The sale of C-BASS, they argue, would increase the value of MGIC and Radian shares because C-BASS’s financial statements would not have to be consolidated with those of the combined entity. CCAC ¶¶ 121, 164; see also Pis.’ Opp. 33-34. These allegations are insufficient to establish motive on the part of the defendants and therefore do not give rise to a strong inference of scienter. The plaintiffs insist that their allegations are not of “the type of corporate transactions that most corporate directors and officers are motivated to complete, but are distinctively unique to Radian.” The plaintiffs fail to point out why these motivations are “distinctively unique,” however. Although not every merger may hinge upon the sale of a particular investment, the motive itself that is alleged by the plaintiffs — the desire to complete a merger and realize the attendant gains on company stock — is among the motives that have been found to be generally possessed by most corporate directors. See GSC Partners, 368 F.3d at 237-38. In addition, the plaintiffs have not alleged any “concrete and personal” benefit to any individual defendant beyond whatever synergies might have resulted from the merger with MGIC. Instead, they allege that the “defendants” were motivated to complete the merger and to artificially inflate the price of Radian stock. CCAC ¶ 164. Not only are these goals generally possessed by most corporate directors, but the plaintiffs also fail to plead motive as to each particular defendant, as required by the PSLRA. See Winer, 503 F.3d at 337. The plaintiffs’ allegations regarding the MGIC merger therefore do not raise a strong inference of scienter. b. Insider Trading The plaintiffs’ allegations regarding insider trading are also insufficient to establish motive on the part of the defendants. Although sales of company stock by insiders that are “unusual in scope or timing” may support an inference of scienter, courts must not infer fraudulent intent from the mere fact that some officers sold stock. In re Suprema, 438 F.3d at 277; In re Advanta Corp. Sec. Litig., 180 F.3d 525, 540 (3d Cir.1999) (quoting In re Burlington Coat Factory Sec. Litig., 114 F.3d 1410, 1424 (3d Cir.1997)). Whether a sale is “unusual in scope” depends on factors such as the amount of profit made, the amount of stock traded, the portion of stockholdings sold, or the number of insiders involved. In re Suprema, 438 F.3d at 277. Other relevant factors are whether the sales were “normal and routine” and whether the profits were substantial relative to the seller’s ordinary compensation. Id. (citing In re Burlington Coat, 114 F.3d at 1423); see also In re Party City Sec. Litig., 147 F.Supp.2d 282, 313 (D.N.J.2001) (“Low aggregate sales and large retained aggregate holdings rebut an inference of motive, even where some defendants have sold significant percentages.” (citing In re Advanta, 180 F.3d at 541)). During the class period, Ibrahim, Quint, and two other individuals — who are not named as defendants in this action— are alleged to have sold 161,804 shares of Radian stock, generating proceeds of approximately $10.2 million. During a period of approximately three months, it further alleges, Radian “insiders” received proceeds from the sale of Radian stock exceeding more than 56% of the stock sale proceeds they received during the twelve months prior to the beginning of the class period. CCAC ¶¶ 162-63. These allegations do not establish motive on the part of the individual defendants' — Casale, Ibrahim, and Quint. First, as to defendant Casale, no mention is made of any sales whatsoever, or of his trading history. This omission raises doubt as to whether the sales were “motivated by an intent to profit from inflated stock prices before the upcoming losses were reported.” In re Advanta, 180 F.3d at 540; In re Burlington Coat, 114 F.3d at 1423; see also Tellabs, 127 S.Ct. at 2511 (counting omissions and ambiguities in the complaint against an inference of scienter). To the contrary, two Forms 4 filed by Casale with the SEC show that Casale more than tripled his investment in Radian stock over the course of the class period. Compare Defs.’ Mot. Ex. 16 at A-685 with Defs.’ Mot. Ex. 17 A-688. Such behavior, the defendants offer, is more consistent with an inference of nonculpability than with a strong inference of scienter. Upon consideration of these publicly filed documents — which is appropriate on a motion to dismiss — and the plaintiffs’ failure to state why Casale’s trading, or lack thereof, was suspicious in scope or in timing, the Court finds that an inference of scienter is not cogent or at least as compelling as an inference of nonculpability. Second, as for Ibrahim, the plaintiffs omit to state that defendant Ibrahim’s sales of 1,095 shares on February 14, 2007, and 5,040 shares on May 14, 2007, represented less than 1% and approximately 2.7% of his total shares and options owned on those respective dates. This fact is confirmed by two Forms 4 filed by Ibrahim with the SEC, the accuracy of which the plaintiffs have not contested. See Defs.’ Mot Ex. 19 at A-694; id. Ex. 20 at A-697. Although the size of Ibrahim’s sales is not itself dispositive, it is significant that even in May of 2007, nearly two months after C-BASS is alleged to have been on the brink of insolvency, Ibrahim continued to hold a “sizable percentage” of his stock. See In re Advanta, 180 F.3d at 540 (declining to find a strong inference of scienter where two corporate defendants sold “only” five and seven percent of their stock holdings, and noting that such facts suggested that the defendants had “every incentive” to keep Advanta profitable). The defendants argue that Ibrahim’s Forms 4 themselves also state nonculpable reasons for the stock trades made by Ibrahim. In particular, the February 14, 2007, sale represented “a portion of the vested shares from a Restricted Stock grant,” indicating that the stock was a portion of Ibrahim’s overall compensation package. See Defs.’ Mot. 28 & Ex. 19 at A-694. As the United States Court of Appeals for the Third Circuit has recognized, many corporate executives receive stock and stock options as a portion of their compensation. It follows, then, that these individuals will trade those securities in the normal course of events. In re Burlington Coat, 114 F.3d at 1424. The plaintiffs have not otherwise alleged that this sale was unusual in scope. As for the May 14, 2007, transaction, the Form 4 for that transaction states that the 5,040 shares Ibrahim sold were sold “to cover taxes on a traunch of restricted stock that vested.” Defs.’ Mot. Ex. 20 at A-697. Other federal courts have found such sales — i.e., sales to cover tax liabilities — as weighing against an inference of scienter. See In re Bristol-Myers Squibb Sec. Litig., 312 F.Supp.2d 549, 561 (S.D.N.Y.2004); Ressler v. Liz Claiborne, Inc., 75 F.Supp.2d 43, 59-60 (S.D.N.Y.1998). Moreover, the public record of Ibrahim’s stock trades reveals that on May 11, 2006, approximately one year earlier, Ibrahim sold 5,468 shares of Radian stock. See Defs.’ Mot. Ex. 18 at A-691. Considering the omissions in the CCAC, Ibrahim’s significant remaining stock holdings, and his trading history, the plaintiffs have not established that Ibrahim’s sales are unusual in scope or in timing. They therefore fail to establish motive on Ibrahim’s part.- In addition, the Court finds that an inference of scienter with respect to Ibrahim is neither cogent nor at least as compelling as the competing nonculpable inferences offered by the defendants. Finally, the CCAC alleges that Quint sold 129,000 shares of common stock on February 8, 2007, representing 68% of his holdings, and generating gross proceeds of $8,105,070. As the defendants point out, however, the plaintiffs do not point to any information to show whether or not this sale was unusual in scope or in timing, other than that it occurred during the class period. The plaintiffs fail to present allegations relating to Quint’s trading history or allegations describing how this sale relates to his overall compensation. Again, such omissions count against an inference of scienter. In addition, the defendants have proffered a nonculpable explanation for Quint’s February 8, 2007 sale, an explanation which is supported by documents of public record. On February 6, 2007, Radian issued a news release, attached to its Form 8-K, which announced the merger with MGIC, and which also identified the persons who would comprise the merged corporation’s management team. Quint, who had been the CFO at Radian, was not listed as among the management team. Instead, the CFO of MGIC was designated as the CFO of the merged company. See Defs.’ Mot. Ex. 4 at A-305. It was in this context, the defendants argue, that Quint made his stock sale; and, as the defendants point out, other courts have found sales by corporate insiders in anticipation of their departures from a company not to be suspicious. See Greebel v. FTP Software, Inc., 194 F.3d 185, 206 (1st Cir.1999) (“It is not unusual for individuals leaving a company ... to sell shares. Indeed, they often have a limited period of time to exercise their company stock options.”); see also Provenz v. Miller, 102 F.3d 1478, 1491 (9th Cir.1996); In re First Union Corp. Sec. Litig., 128 F.Supp.2d 871, 898 (W.D.N.C.2001). Given that Quint made his sale only two days after a public disclosure indicated that he would not be a member of the senior management of the new corporation, the Court does not find the timing of his sale suspicious. Even if the sale were not in keeping with Quint’s previous trading history — of which the plaintiffs make no mention — the sale does not meet the pleading standards under the PSLRA. Rather, again, the plaintiffs’ explanation is not cogent or at least as compelling as the defendants’ explanation. Although the Court finds that none of the individually alleged stock sales adds to a strong inference of scienter with respect to any individual defendant, the Court reaches the same conclusion with respect to the defendants’ collective sales. The CCAC alleges that “Calamari, Kasmar, and Quint sold 95%, 39% and 68% of their Radian common stock holdings.” CCAC ¶ 163. It is not entirely clear who defendants Calamari and Kasmar are, the reason for their inclusion, or whether there were other corporate insiders who either did or did not sell stock during the class period. See supra n. 14. Nevertheless, even considering the timing and quantity of the defendants’ aggregate sales, public documents reveal that the individual defendants actually retained a combined 88.6% of their Radian securities holdings during the class period. See documents cited in Defs.’ Mot. 24 n. 14. This fact, which the plaintiffs have not contested, further undermines a strong inference of scienter based on the alleged insider trading by the defendants. Neither the plaintiffs’ allegations regarding the MGIC merger nor their allegations of insider trading sufficiently establish a motive on the part of the defendants to commit fraud. The plaintiffs thus have not raised a strong inference of scienter through motive and opportunity. In addition, a strong inference of scienter is neither cogent nor at least as compelling as the plausible nonculpable inferences offered by the defendants. 2. Conscious Misbehavior or Recklessness A plaintiff alleging conscious misbehavior or recklessness must show specific facts that constitute “strong circumstantial evidence.” GSC Partners, 368 F.3d at 238. Conscious misbehavior involves “intentional fraud or other deliberate illegal behavior.” In re Advanta, 180 F.3d at 535. Reckless conduct, on the other hand, requires a material representation or omission involving not merely simple, or even inexcusable, negligence, but an “extreme departure” from the standards of ordinary care, and which presents a danger of misleading buyers or sellers that is either known to the defendant or is “so obvious” that the defendant “must have been aware of it.” GSC Partners, 368 F.3d at 239. This standard requires a misrepresentation to be “so recklessly made that the culpability attaching to such reckless conduct closely approaches that which attaches to conscious deception.” In re Digital Island Sec. Litig., 357 F.3d 322, 332 (3d Cir.2004). The plaintiffs’ claim, essentially, is that Radian’s failure to take an impairment charge on its investment in C-BASS earlier than it did constitutes recklessness or conscious misbehavior. More specifically, generally accepted accounting principles (“GAAP”) required Radian to report an impairment charge no later than March 31, 2007, at which point C-BASS is alleged to have been on the brink of insolvency. According to the plaintiffs, C-BASS had held the riskiest subprime securities; the decline in value of these securities led to a multitude of margin calls, the “frequency and magnitude” of which left C-BASS on the brink of insolvency. Pis.’ Opp. 2. As a result, the fair value of Radian’s investment in C-BASS was much less than the reported value, and this decline in value was “other than temporary,” thus requiring a write-down under GAAP — in particular, Accounting Principles Board Opinion No. 18. CCAC ¶ 116. In support of their charge of recklessness, the plaintiffs argue that because Radian maintained an active role in monitoring its investment in C-BASS, the defendants knew or should have known that their actions throughout the class period presented a danger of misleading buyers or sellers. According to the plaintiffs, that the defendants knew or must have known of this danger is evidenced by the defendants’ positions at Radian and C-BASS, by the fact that Radian’s involvement with C-BASS was one of Radian’s core activities, and by the defendants’ knowledge of the risky nature of C-BASS’s business and the deteriorating conditions of the subprime industry. The plaintiffs further argue that their claim of conscious misbehavior or recklessness is supported by the size of the eventual impairment charge taken by Radian, by the resignation of Casale from his position at Radian, and by Deloitte’s decision to decline to stand for reappointment as Radian’s auditor. The Court concludes that the CCAC fails to allege specific facts constituting strong circumstantial evidence that the individual defendants’ actions involved not merely simple, or even inexcusable, negligence, but an extreme departure from the standards of ordinary care. Because the plaintiffs have failed to allege such facts, and because the defendants have provided plausible nonculpable inferences that are more compelling than a strong inference of scienter, the plaintiffs have not met their pleading burden under the PSLRA. a. The C-BASS “Impairment” and GAAP The Supreme Court has acknowledged that GAAP are “far from being a canonical set of rules that will ensure identical accounting treatment of identical transactions.” Thor Power Tool Co. v. Commissioner, 439 U.S. 522, 544, 99 S.Ct. 773, 58 L.Ed.2d 785 (1979). To the contrary, GAAP tolerate a range of “reasonable” treatments, leaving the choice among alternatives to management. Id.; see also In re Intelligroup Sec. Litig., 527 F.Supp.2d 262, 352 (D.N.J.2007) (noting that courts give weight to GAAP violations “only where the provisions of GAAP so coincide with conclusions obvious to any business person ... that a violation of this type ... equates to a self-evident business nonsensicality which cannot be made by a defendant with a nonculpable state of mind”). To accept the plaintiffs’ argument that the decision not to report the C-BASS impairment before July 30, 2007, was an extreme departure from the range of reasonable treatments under GAAP, the Court must first accept that the CCAC sufficiently states that Radian’s investment in C-BASS was actually impaired at some point before March 31, 2007, the date by which C-BASS is alleged to have been on the “brink of insolvency.” However, apart from the plaintiffs’ bald assertions that the value of Radian’s investment in C-BASS was impaired at an earlier date, and that a write-down should have been made no later than March 31, 2007, the CCAC fails to allege any such impairment with sufficient particularity. To the contrary, both the allegations of the CCAC and the public record of C-BASS’s margin calls lead the Court to the opposite inference, advanced by the defendants: that C-BASS was not on the brink of insolvency on March 31, 2007. According to the CCAC, in late July 2007, Radian announced that C-BASS could no longer meet its margin calls. It was at that point that both Radian and MGIC wrote down their investments in C-BASS. Although the CCAC alleges that C-BASS faced a liquidity crisis that left it on the brink of insolvency by March 31, 2007, it also acknowledges, without disputing or contradicting, C-BASS’s statement that during the first six months of 2007, a “disciplined liquidity strategy” enabled the company to meet $290 million in lender margin calls, and that during the first twenty-four days of July alone, C-BASS met an additional $260 million of margin calls. CCAC ¶ 149; see also Pis.’ Opp. 7. Even if an impairment of Radian’s investment did occur at some point earlier than Radian ultimately stated, the plaintiffs do not allege facts to show that Radian’s decision not to report whatever impairment may have existed until July 2007 involved not merely simple, or even inexcusable negligence, but an extreme departure from the range of reasonable business treatments permitted under GAAP. The defendants point out, for example, that Deloitte, Radian’s auditor during the class period, did not dispute Radian’s decision to write down its investment in C-BASS when it did. As support, the defendants offer a letter from Deloitte attached to Radian’s Form 8-K, filed October 2, 2007, in which Deloitte “agree[d]” with Radian’s statement that any issues relating to the filing of Radian’s Form 10-Q/A for the second quarter of 2007 were resolved without any changes to Radian’s interim financial statements. Even if, as the plaintiffs suggest, this evidence does not specifically establish that Deloitte “agreed” with Radian’s treatment of the C-BASS write-down, the fact remains that Deloitte and Radian resolved the matter without further amendments to Radian’s SEC filings. Rather than supporting a strong inference of scienter, this fact more plausibly suggests that Radian’s report was not viewed by Deloitte as an extreme departure from the range of reasonable treatments permitted under GAAP. As further evidence that the defendants’ decision to take an impairment charge in July 2007 was not an extreme departure from the range of reasonable business decisions, the defendants offer that MGIC also chose not to report an impairment earlier than Radian, and, like Radian, reported the C-BASS impairment as a third-quarter event in its 10-Q filed November 21, 2007. See Defs.’ Ex. 25, at A-767-68. The plaintiffs respond that the fact that another company may conceal material information or make fraudulent statements cannot absolve the defendants of liability. Pis.’ Opp. 19. Leaving aside the lack of allegations regarding whether MGIC also concealed material information or made fraudulent statements, the timing of MGIC’s report nonetheless adds to the Court’s conclusion that the plaintiffs have not shown strong circumstantial evidence that the defendants’ actions constitute an extreme departure from the standards of ordinary care. b. Allegations That the Defendants “Knew” or “Must Have Known” of the C-BASS Impairment The plaintiffs argue that because Radian maintained an active role in monitoring its investment in C-BASS, the defendants knew or must have known that their statements or omissions during the class period — including their representations that their interim financial statements had been prepared in accordance with GAAP and the Sarbanes-Oxley Act (“SOX”) — presented a danger of misleading buyers or sellers. As a preliminary matte